Approval · Notice of Compliance 16069 · 2014
ACT EZETIMIBE: Notice of Compliance 16069
Issued September 15, 2014
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 16069
- Date
- September 15, 2014
- Company
- Actavis Pharma CompanyToronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Other
- Therapeutic class
- Cholesterol absorption inhibitor
- Canadian reference product
- EZETROL (Merck Canada Inc)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ACT EZETIMIBE | 02414716 | Cancelled Post Market |
Medicinal ingredients
- EZETIMIBE 10 MG per TAB